It is thus our opinion, as clinicians, scientists, and AKI experts, that novel biomarkers, such as NGAL and TIMP-2•IGFBP7, have considerable utility in the diagnosis and prognosis of AKI. Here, IGFBP7 is linked to acute kidney injury.